Angiogenesis inhibitor
Epidermal growth factor receptor inhibitor
Piperidine derivative
Protein-tyrosine kinase inhibitor
Quinazoline
Vascular endothelial growth factor receptor antagonist
|
|
|
|
|
|
Vandetanib (substance)
Vandetanib
Id
418260004
Status
Primitive
Has disposition
Angiogenesis inhibitor
Has disposition
Epidermal growth factor receptor inhibitor
Has disposition
Protein-tyrosine kinase inhibitor
Has disposition
Vascular endothelial growth factor receptor antagonist